Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.36 |
| ▸ | CTSA | P10619 | 8/20 | 0.35 |
| ▸ | CYP26A1 | O43174 | 3/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.32 |
| ▸ | ITGA4 | P13612 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL688854 | 0.91 | PPARG (0.39) | CTSACYP26A1ATML3MBTL1PTGER3 | |
| SCHEMBL687280 | 0.86 | POLB (0.43) | CTSACYP26A1PTGER3MEN1POLB | |
| SCHEMBL688295 | 0.85 | MEN1 (0.39) | PTGDR2CYP26A1MEN1POLBKMT2A | |
| SCHEMBL688191 | 0.85 | ALDH1A1 (0.40) | CTSACYP26A1PTGER3MEN1POLB | |
| SCHEMBL688155 | 0.85 | PTGER3 (0.49) | CTSAPTGER3MEN1POLBKMT2A | |
| SCHEMBL687761 | 0.85 | CTSA (0.46) | CTSAPTGER3MEN1KMT2AALDH1A1 | |
| SCHEMBL688040 | 0.85 | PTGER3 (0.49) | CTSAPTGER3MEN1POLBKMT2A | |
| SCHEMBL688110 | 0.84 | MEN1 (0.49) | CTSACYP26A1MEN1POLBKMT2A | |
| SCHEMBL687559 | 0.83 | ALDH1A1 (0.49) | CTSAPTGER3POLBALDH1A1 | |
| SCHEMBL688296 | 0.83 | CTSA (0.37) | CTSACYP26A1PTGER3MEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1203766-B1 | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors | ENCYSIVE PHARMACEUTICALS INC (US) | 2012-02-29 | — | — | EP | disclosed |
| EP-1203766-A2 | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors | TEXAS BIOTECHNOLOGY CORPORATION (US) | 2002-05-08 | — | — | EP | disclosed |